Story perspectives

Over Half of Danish Non-Diabetics Quit Semaglutide Within Year

9/15/2025

49 4

Summary

Story summary

A study at the EASD in Vienna shows over half of Danish adults without diabetes stop semaglutide treatment within a year.
Of 77,310 users, 40,262 discontinued after one year, with 18%, 31%, and 42% stopping at 3, 6, and 9 months, respectively.
High annual costs of around €2,000 deter younger users (18-29 years), who are 48% more likely to discontinue.
Users in low-income areas are 14% more likely to stop treatment than those in high-income areas.
Those with psychiatric or gastrointestinal issues also exhibit higher discontinuation rates.

1 of 1

Story summary

A study at the EASD in Vienna shows over half of Danish adults without diabetes stop semaglutide treatment within a year.
Of 77,310 users, 40,262 discontinued after one year, with 18%, 31%, and 42% stopping at 3, 6, and 9 months, respectively.
High annual costs of around €2,000 deter younger users (18-29 years), who are 48% more likely to discontinue.
Users in low-income areas are 14% more likely to stop treatment than those in high-income areas.
Those with psychiatric or gastrointestinal issues also exhibit higher discontinuation rates.